Rajangam Kanya
SEC CIK 1816676 · EDGAR
BoughtSold
Most active insiders at SNTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lu Timothy K | CEO, Dir | — | — |
| 2 | Rajangam Kanya | Pres, Chief Med, Dev. Off | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | 2026-03-09 | SNTI | Senti Biosciences Holdings, Inc. | Rajangam Kanya | Pres, Chief Med, Dev. Off | F - Tax | $0.00 | -10.8K | 74.8K | -13% | $0 | |
| 2026-02-03 | 2026-02-02 | SNTI | Senti Biosciences Holdings, Inc. | Rajangam Kanya | Pres, Chief Med, Dev. Off | F - Tax | $0.00 | -1,384 | 85.6K | -2% | $0 | |
| DI | 2025-03-11 | 2025-03-10 | SNTI | Senti Biosciences Holdings, Inc. | Rajangam Kanya | Pres, Chief Med, Dev. Off | C - Cnv Deriv | $2.25 | +33.0K | 33.0K | New | +$74.2K |
| D | 2025-03-10 | 2025-03-07 | SNTI | Senti Biosciences Holdings, Inc. | Rajangam Kanya | Pres, Chief Med, Dev. Off | A - Grant | $0.00 | +78.4K | 87.0K | +909% | $0 |
| M | 2025-02-06 | 2025-02-04+ | SNTI | Senti Biosciences Holdings, Inc. | Rajangam Kanya | Pres, Chief Med, Dev. Off | S - Sale | $4.11 | -1,479 | 8,621 | -15% | -$6,074 |
| D | 2024-02-02 | 2024-02-01 | SNTI | Senti Biosciences Holdings, Inc. | Rajangam Kanya | Chief Medical, Devt. Off | A - Grant | $0.00 | +101.0K | 101.0K | New | $0 |
| D | 2022-01-19 | 2022-01-14 | NKTX | Nkarta, Inc. | Rajangam Kanya | Chief Medical Off | A - Grant | $0.00 | +12.8K | 12.8K | New | $0 |
| D | 2021-08-09 | 2021-08-05 | NKTX | Nkarta, Inc. | Rajangam Kanya | Chief Medical Off | M - OptEx | $0.41 | +10.0K | 10.0K | New | +$4,100 |
| D | 2021-08-09 | 2021-08-05 | NKTX | Nkarta, Inc. | Rajangam Kanya | Chief Medical Off | S - Sale+OE | $37.28 | -10.0K | 0 | -100% | -$372.8K |
Purchase Sale Sale after option exercise All abbreviations